Polycythemia Vera Treatment Algorithm 2018

Doctors outline their recommended strategy for treating polycythemia vera, including how to handle low-risk versus high-risk disease; what first-, second-, and third-line drugs are appropriate; and when to consider JAK2 inhibitor therapy.  

 Blood Cancer Journal

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.